• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肿瘤基因组测序分析中的种系变异鉴定。

Identification of Germline Variants in Tumor Genomic Sequencing Analysis.

机构信息

Department of Pathology and Laboratory Medicine, The University of North Carolina School of Medicine, Chapel Hill, North Carolina; Lineberger Comprehensive Cancer Center, The University of North Carolina School of Medicine, Chapel Hill, North Carolina.

Lineberger Comprehensive Cancer Center, The University of North Carolina School of Medicine, Chapel Hill, North Carolina.

出版信息

J Mol Diagn. 2018 Jan;20(1):123-125. doi: 10.1016/j.jmoldx.2017.09.008.

DOI:10.1016/j.jmoldx.2017.09.008
PMID:29249243
Abstract

This Correspondence relates to the article by Li et al (Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and the College of American Pathologists. J Mol Diagn 2017, 19:4-23).

摘要

这封通信是关于李等人的文章（《癌症序列变异解释和报告的标准和指南：分子病理学协会、美国临床肿瘤学会和美国病理学家学院的联合共识建议》。J Mol Diagn 2017, 19:4-23）。

相似文献

1
Identification of Germline Variants in Tumor Genomic Sequencing Analysis.肿瘤基因组测序分析中的种系变异鉴定。
J Mol Diagn. 2018 Jan;20(1):123-125. doi: 10.1016/j.jmoldx.2017.09.008.
2
Authors' Reply.作者回复。
J Mol Diagn. 2018 Jan;20(1):125-126. doi: 10.1016/j.jmoldx.2017.11.002.
3
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.癌症序列变异解读与报告的标准和指南：分子病理学协会、美国临床肿瘤学会和美国病理学家学会联合共识推荐
J Mol Diagn. 2017 Jan;19(1):4-23. doi: 10.1016/j.jmoldx.2016.10.002.
4
A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.一种计算方法，用于从无匹配正常样本的癌症标本深度测序中区分基因组改变的体细胞起源与种系起源。
PLoS Comput Biol. 2018 Feb 7;14(2):e1005965. doi: 10.1371/journal.pcbi.1005965. eCollection 2018 Feb.
5
The emerging significance of secondary germline testing in cancer genomics.肿瘤基因组学中胚系二次检测的新兴意义。
J Pathol. 2018 Apr;244(5):610-615. doi: 10.1002/path.5031. Epub 2018 Feb 16.
6
Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants.变体解读癌症工具（VIC）：一个用于评估体细胞变异临床影响的计算工具。
Genome Med. 2019 Aug 23;11(1):53. doi: 10.1186/s13073-019-0664-4.
7
Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer.基于 2017 年美国分子病理学会、美国临床肿瘤学会和美国病理学家学院标准和指南对癌症中序列变异的解释和报告的多机构评价，变体分类的评价者间一致性。
J Mol Diagn. 2020 Feb;22(2):284-293. doi: 10.1016/j.jmoldx.2019.10.010. Epub 2019 Dec 16.
8
Exploring the Link between the Germline and Somatic Genome in Cancer.探索癌症中生殖系基因组与体细胞基因组之间的联系。
Cancer Discov. 2017 Apr;7(4):354-355. doi: 10.1158/2159-8290.CD-17-0192.
9
Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profiling.通过仅肿瘤的全面基因组分析对疑似胚系致病性变异进行胚系测序。
Int J Clin Oncol. 2022 Aug;27(8):1256-1263. doi: 10.1007/s10147-022-02176-y. Epub 2022 May 14.
10
Assessments of Somatic Variant Classification Using the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists Guidelines: A Report from the Association for Molecular Pathology.使用分子病理学协会/美国临床肿瘤学会/美国病理学家学会指南进行体细胞变异分类评估：分子病理学协会报告
J Mol Diagn. 2023 Feb;25(2):69-86. doi: 10.1016/j.jmoldx.2022.11.002. Epub 2022 Dec 9.

引用本文的文献

1
Clonal Hematopoietic Mutations in Plasma Cell Disorders: Clinical Subgroups and Shared Pathogenesis.浆细胞疾病中的克隆性造血突变：临床亚组与共同发病机制
Genomics Proteomics Bioinformatics. 2025 May 30;23(2). doi: 10.1093/gpbjnl/qzaf027.
2
Clinical integration of germline findings from a tumor testing precision medicine program.肿瘤检测精准医学项目中种系结果的临床整合
BMC Cancer. 2025 Jan 30;25(1):176. doi: 10.1186/s12885-025-13487-4.
3
Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor Board.
肿瘤和胚系测序检测到的基因组改变的一致性：来自三级护理学术中心分子肿瘤委员会的结果。
Oncologist. 2023 Jan 18;28(1):33-39. doi: 10.1093/oncolo/oyac164.
4
Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing.使用靶向新一代DNA测序追踪多发性骨髓瘤的克隆进化
Biomedicines. 2022 Jul 12;10(7):1674. doi: 10.3390/biomedicines10071674.
5
Attribution of Cancer Origins to Endogenous, Exogenous, and Preventable Mutational Processes.归因于内源性、外源性和可预防的突变过程的癌症起源。
Mol Biol Evol. 2022 May 3;39(5). doi: 10.1093/molbev/msac084.
6
Integrating Medical Genetics Into Precision Oncology Practice in the Veterans Health Administration: The Time Is Now.将医学遗传学纳入退伍军人健康管理局的精准肿瘤学实践：现在是时候了。
JCO Oncol Pract. 2022 Jun;18(6):e966-e973. doi: 10.1200/OP.21.00693. Epub 2022 Mar 8.
7
Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor.胚系测序提高了小儿实体瘤精准基因组研究中仅肿瘤测序解释的准确性。
JCO Precis Oncol. 2021 Dec 22;5. doi: 10.1200/PO.21.00281. eCollection 2021.
8
Identification of Variants Associated With Rare Hematological Disorder Erythrocytosis Using Targeted Next-Generation Sequencing Analysis.使用靶向新一代测序分析鉴定与罕见血液疾病红细胞增多症相关的变异体
Front Genet. 2021 Jul 19;12:689868. doi: 10.3389/fgene.2021.689868. eCollection 2021.
9
Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies.杂合子种系CSF3R变异作为血液系统恶性肿瘤发生的风险等位基因。
Blood Adv. 2020 Oct 27;4(20):5269-5284. doi: 10.1182/bloodadvances.2020002013.
10
Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer.癌症患者肿瘤测序后种系检测的产量和效用。
JAMA Netw Open. 2020 Oct 1;3(10):e2019452. doi: 10.1001/jamanetworkopen.2020.19452.